We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$7.28M
(-6.5%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-7.33%
Top 10 Holdings %
Top 10 Hldgs %
26.55%
Holding
118
New
2
Increased
12
Reduced
41
Closed
12
Avg Time Held
4.9
quarters
Top 10 Avg Time Held
2.4
quarters
Top 20 Avg Time Held
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
|
+$939K |
| 2 |
LMRK
Landmark Infrastructure Partners LP Common Units
LMRK
|
+$519K |
| 3 |
AGN
Allergan plc
AGN
|
+$315K |
| 4 |
VivoSim Labs
VIVS
|
+$238K |
| 5 |
Navigator Holdings
NVGS
|
+$130K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harvard Bioscience
HBIO
|
+$1.62M |
| 2 |
CALL
magicJack VocalTec Ltd
CALL
|
+$938K |
| 3 |
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
|
+$933K |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$829K |
| 5 |
AFFX
Affymetrix Inc
AFFX
|
+$802K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.52% |
| 2 | Healthcare | 14.97% |
| 3 | Miscellaneous | 13.49% |
| 4 | Financials | 10.99% |
| 5 | Energy | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$171B
| $7.17M | 6.81% |
262,000
-1,800
| -0.7% | -$50.6K |
2013 Q4
6 quarters
|
|
2
Microsoft
MSFT
$3.97T
| $3.63M | 3.45% |
82,194
-500
| -0.6% | -$22.8K |
2013 Q4
6 quarters
|
|
3
Fidelity National Financial
FNF
$10.4B
| $2.59M | 2.46% |
100,858
-4,552
| -4% | -$118K |
2013 Q4
6 quarters
|
|
4
Alphabet (Google) Class C
GOOG
$4.25T
| $2.39M | 2.27% |
90,120
-1,411
| -2% | -$37.8K |
2013 Q4
6 quarters
|
|
5
GE Aerospace
GE
$320B
| $2.22M | 2.1% |
17,400
+252
| +1% | +$32.7K |
2013 Q4
6 quarters
|
|
6
Immersion
IMMR
$247M
| $2.16M | 2.06% |
170,786
| – | – |
2013 Q4
6 quarters
|
|
|
ZIXI
7
DELISTED
Zix Corporation
ZIXI
| $2.05M | 1.94% |
395,956
| – | – |
2013 Q4
6 quarters
|
|
8
Synopsys
SNPS
$97.7B
| $1.98M | 1.88% |
39,110
-540
| -1% | -$26.3K |
2013 Q4
6 quarters
|
|
|
FEIC
9
DELISTED
FEI COMPANY
FEIC
| $1.91M | 1.81% |
23,035
| – | – |
2013 Q4
6 quarters
|
|
10
Moody's
MCO
$80.4B
| $1.86M | 1.76% |
17,200
-300
| -2% | -$32.3K |
2013 Q4
6 quarters
|
|
|
XCRA
11
DELISTED
Xcerra Corporation
XCRA
| $1.74M | 1.66% |
230,451
+10,000
| +5% | +$89.7K |
2013 Q4
6 quarters
|
|
|
ARRS
12
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.72M | 1.63% |
56,052
-315
| -0.6% | -$10.2K |
2013 Q4
6 quarters
|
|
13
Data I/O
DAIO
$30.3M
| $1.68M | 1.59% |
490,700
| – | – |
2013 Q4
6 quarters
|
|
|
EPAY
14
DELISTED
Bottomline Technologies Inc
EPAY
| $1.62M | 1.54% |
58,240
-5,670
| -9% | -$156K |
2013 Q4
6 quarters
|
|
|
ESIO
15
DELISTED
Electro Scientific Industries
ESIO
| $1.59M | 1.51% |
301,835
| – | – |
2013 Q4
6 quarters
|
|
16
Axcelis
ACLS
$4.16B
| $1.56M | 1.49% |
132,165
-180
| -0.1% | -$2.08K |
2013 Q4
6 quarters
|
|
17
First American
FAF
$6.25B
| $1.55M | 1.47% |
41,683
-400
| -1% | -$14.3K |
2013 Q4
6 quarters
|
|
|
SHOR
18
DELISTED
ShoreTel, Inc.
SHOR
| $1.53M | 1.45% |
225,900
| – | – |
2013 Q4
6 quarters
|
|
19
State Street SPDR S&P 500 ETF Trust
SPY
$833B
| $1.51M | 1.43% |
7,315
| – | – |
2014 Q1
5 quarters
|
|
20
DELISTED
2U Inc
TWOU
| $1.5M | 1.43% |
1,557
| – | – |
2014 Q2
4 quarters
|
|
21
Targa Resources
TRGP
$61.5B
| $1.5M | 1.43% |
16,826
| – | – |
2013 Q4
6 quarters
|
|
22
Thomson Reuters
TRI
$44.7B
| $1.49M | 1.42% |
33,822
-689
| -2% | -$32.3K |
2013 Q4
6 quarters
|
|
|
PRCP
23
DELISTED
Perceptron Inc
PRCP
| $1.49M | 1.42% |
141,406
| – | – |
2013 Q4
6 quarters
|
|
24
Halliburton
HAL
$27.1B
| $1.49M | 1.42% |
34,625
+1,400
| +4% | +$64.5K |
2014 Q4
2 quarters
|
|
25
Teradyne
TER
$63B
| $1.41M | 1.34% |
73,280
| – | – |
2013 Q4
6 quarters
|
|
Similar funds
AFW
QGA
AWA
BGAI
AIG
MFG
BCM
MCM
Penbrook Management's Q2 2015 Portfolio in Review
As of Q2 2015, Penbrook Management held 118 positions worth $105M, down 6.5% from $113M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Penbrook Management withdrew a net $7.72M in Q2 2015, closing 12 positions and reducing 41 holdings. Its most notable exit was magicJack VocalTec Ltd, an estimated $938K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, Penbrook Management opened a new position in Landmark Infrastructure Partners LP Common Units worth $491K.
- Penbrook Management's largest Q2 2015 buy was Landmark Infrastructure Partners LP Common Units: 30,400 shares worth $491K.
- Penbrook Management added most to ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS in Q2 2015, an estimated $939K increase.
- Penbrook Management's biggest Q2 2015 reduction was Harvard Bioscience, cutting an estimated $1.62M.
- Penbrook Management fully exited magicJack VocalTec Ltd in Q2 2015, selling an estimated $938K.
- Penbrook Management's ten largest holdings make up 27% of its $105M portfolio in Q2 2015.
- Penbrook Management opened 2 new positions and closed 12 in Q2 2015.
- Penbrook Management's portfolio value fell 6.5% quarter-over-quarter to $105M.
Based on Penbrook Management's 13F filing for Q2 2015, filed 4 Aug 2015.